What role does Pharmakogenetik Medicheck play in Sport?

The role of pharmacogenetics in sport is often discussed in the context of personalized drug strategies – e.g., adjusting painkillers, asthma medications, or avoiding adverse effects. However, the 'Pharmakogenetik Medicheck' you mention is not a specific MyBody-X product referenced in the provided knowledge base. The available articles and Q&A batches cover DNA tests for metabolism, nutrition, sports genetics (e.g., ACTN3, FADS), and longevity. There is no evidence that MyBody-X offers a separate pharmacogenetics test for athletes, or that their existing tests provide clinically validated drug-gene interaction guidance for sports. The evidence for pharmacogenetics in sport is generally weak: most studies are mechanistic or GWAS-based with small effect sizes; randomized controlled trials are lacking. Athletes should not base medication decisions on single genetic variants without medical supervision. If MyBody-X does offer such a test, the evidence level would be 'marketing' or 'unclear', as clinical relevance for sports practice is unproven.